|
|
This indicator measures the percentage of long-term care home residents whose mood from symptoms of depression worsened since their previous resident assessment. Depression affects quality of life and may also contribute to deteriorations in activities of daily living (ADLs) and an increased sensitivity to pain. The indicator is calculated as a rolling four quarter average. This indicator was jointly developed by interRAI and the Canadian Institute for Health Information (CIHI). A lower percentage is better.
| 06/10/2025 |
|
Add to compare
|
|
|
This indicator measures the percentage of long-term care home residents without psychosis who were given antipsychotic medication in the seven days preceding their resident assessment. Residents were excluded from this indicator if they had a diagnosis of schizophrenia or Huntington's chorea, experienced hallucinations or delusions, have an end-stage disease or are receiving hospice/palliative care. These drugs are sometimes used to manage behaviours in residents who have dementia. Careful monitoring is required, as such use raises concerns about safety and quality of care. The indicator is calculated as a rolling four quarter average. This indicator was jointly developed by interRAI and the Canadian Institute for Health Information (CIHI). A lower percentage is better.
| 06/10/2025 |
|
Add to compare
|
|
|
Percentage of non-palliative patients newly dispensed an opioid prescribed by any provider in the health care system within a 6-month reporting period.
| 20/12/2019 |
|
Add to compare
|
|
|
This indicator measures the
percentage of non-palliative patients
newly prescribed an opioid by a provider
in your organization within a 6-
month reporting period.
| 20/12/2019 |
|
Add to compare
|
|
|
This indicator measures the percentage of Ontario screen-eligible women, 21-69 years old, who completed at least one Pap test in 42-month period.
| 04/03/2019 |
|
Add to compare
|
